SRC and neuroblastoma: Earlier studies using tyrosine kinase inhibitors to block Src demonstrated sensitivity of NB cells to the non-specific Src inhibitors such as dasatanib [10], PP2 [11, 25] and other SFK inhibitors [3, 9, 26].